These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25470396)

  • 1. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
    McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
    CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
    McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A
    Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder.
    Bakkour N; Samp J; Akhras K; El Hammi E; Soussi I; Zahra F; Duru G; Kooli A; Toumi M
    Psychiatry Res; 2014 May; 216(3):291-302. PubMed ID: 24656516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social cognitive abilities predict psychosocial dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Depress Anxiety; 2019 Jan; 36(1):54-62. PubMed ID: 30211966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using measurement strategies to identify and monitor residual symptoms.
    McIntyre RS
    J Clin Psychiatry; 2013; 74 Suppl 2():14-8. PubMed ID: 24191973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognition - the core of major depressive disorder].
    Polosan M; Lemogne C; Jardri R; Fossati P
    Encephale; 2016 Feb; 42(1 Suppl 1):1S3-11. PubMed ID: 26879254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Curr Opin Psychiatry; 2018 Jan; 31(1):26-31. PubMed ID: 29076892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder.
    Zuckerman H; Pan Z; Park C; Brietzke E; Musial N; Shariq AS; Iacobucci M; Yim SJ; Lui LMW; Rong C; McIntyre RS
    Front Psychiatry; 2018; 9():655. PubMed ID: 30564155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction and work productivity in major depressive disorder.
    Clark M; DiBenedetti D; Perez V
    Expert Rev Pharmacoecon Outcomes Res; 2016 Aug; 16(4):455-63. PubMed ID: 27268275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.
    Woo YS; Rosenblat JD; Kakar R; Bahk WM; McIntyre RS
    Clin Psychopharmacol Neurosci; 2016 Feb; 14(1):1-16. PubMed ID: 26792035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.
    Godard J; Grondin S; Baruch P; Lafleur MF
    Psychiatry Res; 2011 Dec; 190(2-3):244-52. PubMed ID: 21764461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.
    Papakostas GI
    J Clin Psychiatry; 2014 Jan; 75(1):8-14. PubMed ID: 24345473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments.
    Bortolato B; Carvalho AF; Soczynska JK; Perini GI; McIntyre RS
    Curr Neuropharmacol; 2015; 13(5):558-76. PubMed ID: 26467407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.